IDTechEx Research: Bioelectronic Medicine - a Drug-Free Solution to Chronic Diseases

Monday, March 25, 2019 Drug News
Email Print This Page Comment bookmark
Font : A-A+

BOSTON, March 25, 2019 /PRNewswire/ -- Bioelectronic medicine, referring to technologies that utilize electrical stimulation

to treat conditions of the human body, has been in use for many decades for the treatment of cardiac conditions. As companies continue to develop and commercialize new technologies, we are expecting significant growth in the industry. In 2018, bioelectronic
medicine was named by the World Economic Forum as one of the ten top technologies to change medical treatment. IDTechEx Research's market intelligence report Bioelectronic Medicine 2019 – 2029 forecasts the market to reach $60 billion by the year 2029.

To learn more about this exciting and disruptive technology, join the IDTechEx masterclass "Bioelectronic Medicine & Neuroprosthetics" on 12 April 2019 at the Estrel Convention Center in Berlin, Germany. For more information on the masterclass, please refer to https://www.idtechex.com/europe2019/show/en/masterclasses.

In this earnings season, we have already seen proof of significant growth in bioelectronic medicine. Double-digit growth has been reported in stimulators for the central nervous system (CNS), particularly, 2 spinal cord stimulators. The spinal cord stimulator is a device that is being used for the treatment of chronic pain. By disrupting the pain signaling pathways of the body with electrical stimulation, spinal cord stimulation is a drug-free solution that can address the ongoing opioid crisis. With increasing awareness of the value of bioelectronic medicine, more and more patients will be driven to bioelectronic therapies, rather than opioid painkillers.

In addition to the use of spinal cord stimulators to solve the opioid epidemic, there are countless other opportunities for market growth in bioelectronic medicine. LivaNova, a company that has developed a device for the treatment of epilepsy, reported 13 percent YoY growth in 2018. Axonics, a company that has recently commercialized a sacral nerve stimulator, brings much needed market disruption in an area dominated by medical device giant Medtronic. As market disruption in spinal cord stimulation has forced companies to innovate, patients suffering from overactive bladder and incontinence may look forward to new technologies to help manage their conditions.

To learn more about bioelectronic medicine, including technology and market trends, please refer to the IDTechEx report: Bioelectronic Medicine 2019 – 2029. Visit www.IDTechEx.com/bioelec or contact research@IDTechEx.com.

IDTechEx guides your strategic business decisions through its Research, Consultancy and Events services, helping you profit from emerging technologies. Find out more at www.IDTechEx.com. 

Media Contact:Charlotte MartinMarketing & Research Coordinatorc.martin@IDTechEx.com+44(0)1223 812300

Related Links

Further IDTechEx Research

IDTechEx Show!

Cision View original content:http://www.prnewswire.com/news-releases/idtechex-research-bioelectronic-medicine---a-drug-free-solution-to-chronic-diseases-300817743.html

SOURCE IDTechEx



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store